MEDI-CAPS LIMITED has reported its financial results for the fiscal year ended March 31, 2026. The company posted a net loss of ₹13.87 Lakhs on a standalone basis, a change from a profit of ₹55.51 Lakhs in the previous year. On a consolidated basis, the net loss widened to ₹303.75 Lakhs from ₹57.10 Lakhs in the prior year. Key financial ratios indicate a decrease in profitability metrics and inventory turnover.
Annual Financial Performance
MEDI-CAPS LIMITED has announced its financial performance for the fiscal year ended March 31, 2026. The company’s standalone operations reported a total income of ₹288.24 Lakhs, down from ₹297.91 Lakhs in the previous fiscal year. Consequently, the company recorded a net loss of ₹13.87 Lakhs for the year, a significant shift from the profit of ₹55.51 Lakhs reported in the prior year.
Consolidated Financial Highlights
On a consolidated basis, which includes its wholly-owned subsidiary Medgel Private Limited, the company’s total income stood at ₹2,065.64 Lakhs for FY 2025-26, compared to ₹2,820.66 Lakhs in the previous year. The consolidated financial statements reflect a net loss of ₹303.75 Lakhs, an increase from the ₹57.10 Lakhs net loss recorded in FY 2024-25.
Key Financial Ratios
Analysis of key financial ratios for FY 2025-26 reveals several changes. The Current Ratio improved to 92.65 times from 81.65 times, primarily due to a decrease in current liabilities. However, the Return on Equity Ratio saw a significant decrease, dropping to -0.0021 times from 0.0083 times, attributed to the year’s loss. Similarly, the Net Profit Ratio declined to -5.40% from 11.79%, also due to the net loss incurred during the year.
The Inventory Turnover Ratio decreased to 0.13 times from 0.15 times. The Trade Receivables Turnover Ratio also experienced a decline, falling to 0.69 times from 0.58 times. The Net Capital Turnover Ratio remained relatively stable at 0.11 times.
Source: BSE
